by bmgureta | February 8, 2017 9:32 pm
Looks like a winner: phase2B completed in april17 with promising results from compassionate use trials- should get fast track approval for phase 3- would be interested in your opinion
Source URL: https://www.stockgumshoe.com/2017/02/microblog-innate-immunotherapeutics/
Copyright ©2024 Stock Gumshoe unless otherwise noted.
Leave a Reply